Newspaper publication dated 27th May, 2026 for Audited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Year ended 31st March, 2026 approved by the Board ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Eiko Lifesciences Ltd published its audited financial results for Q4 and the full year ended March 31, 2026. The Board of Directors approved the results at their meeting on May 26, 2026. For the standalone entity, Q4 FY26 total income stood at Rs. 4,425.61 lakhs with net profit of Rs. 471.30 lakhs, while FY26 full-year total income was Rs. 5,367.94 lakhs with net profit of Rs. 706.47 lakhs. Consolidated Q4 FY26 net profit was Rs. 149.33 lakhs compared to Rs. 85.46 lakhs in Q4 FY25, representing a ~75% year-on-year increase in quarterly net profit. The results were published in Mumbai Lakshadeep (Marathi) and Financial Express (English) newspapers on May 27, 2026, as per SEBI LODR Regulations 30 and 47.
Strong year-on-year profit growth signals operational improvement. The ~75% YoY jump in Q4 net profit and full-year net profit nearly tripling from Rs. 258.04 to Rs. 706.47 lakhs is a positive indicator for shareholders, reflecting better operational efficiency.